Whether you agree going without running shoes in principle or not, testing for illicit drug abuse is a reality for many people workers in the United states. Drug testing is mandatory for federal employees, and although it is not required in the private sector, more employers are implementing some kind(s) of drug screening.
When drug testing is mandated, employers almost always follow the SAMHSA (Substance Abuse and Mental Health Services Administration) guidelines since the device puts them on solid legal ground. Typically, there is an overlap between testing guidelines and accepted cutoff levels for drugs and drug metabolites in confirmatory testing and screening.
Because THC is widely recognized as being responsible for marijuana’s psychoactivity and euphoria, a routine urine drug screen for marijuana use consists of an immunoassay with antibodies that were made to detect it, and its main metabolite, 11-nor-delta9-caboxy-THC (THC-COOH). SAMHSA has set the cutoff level for much better deals urine screen in the immunoassay at 50 ng/mL. When the immunoassay screen is positive at the > 50 ng/mL level, a confirmatory GC/MS (Gas Chromatography/Mass Spectrometry) test is over to verify the positive urine screen. The confirmatory GC/MS has a cutoff level of 15 ng/mL and is specific and the 11-nor-THCCOOH metabolite.
Fortunately, the urine drug screen for THC-COOH could have very little cross-reactivity to other cannabinoids that aren’t psychoactive, such as CBD (cannabidiol), CBG (cannabigerol), CBN (cannabinol), and others. Many . good news for normal consumers of Wholesale CBD Full Spectrum Oil.
That said, individuals using unusually large doses within the cannabinoid-rich hemp oil product (above 1000-2000 mg of hemp oil daily) could theoretically test positive in initial urinary screen. Although very rare, the urine screen in these cases would likely represent an incorrect positive due to other non-THC metabolites or compounds, which may cross-react without the pain . immunoassay. When this could be the case, the confirmatory GC/MS test would be negative, since CBD and other cannabinoids will not be detected by the more accurate (and specific) GC/MS touch screen.
Keep in mind that many of the high-quality, reliable CBD-rich hemp oil products contain much less THC than marijuana. For example, hemp contains anywhere from 1/10th to 1/300th with the THC concentration found in marijuana. An individual consuming 1000-2000 mg per day of hemp oil would thus consume approximately 3-6 mg of THC. This exceedingly high dose may provide detection of positive urine screen in up to 11% to 23% of assays.
On the other hand, there is some data demonstrating that at daily doses of 0.5mg of THC from 3-5 servings of most commercial CBD-rich hemp oil products, good urine screen rates are < 0.2%. Again, most servings of typical high-quality, high-purity CBD-based hemp oil products contain well below 0.1mg of THC and therefore have over 400-600 times less THC than marijuana services. What does involves mean? Put simply, a consumer who uses a high-quality, scientifically vetted hemp-based product at although serving size is tremendously unlikely to test positive for THC and/or THC-COOH. However, it’s important pertaining to being cognizant that higher than normal doses may result in positive urine screen (that would be subsequently shown regarding false via GC/MS). Ultimately, consumers has fully informed with the specific regulations presented by their employers and adjust their use of cannabinoid products accordingly.